a year ago
RXDX
AnalystsGregory RenzaGregory Renza's Stock Forecasts
AnalystsGregory Renza
Analyst Ranking
Top 3%
#104 out of 4554 analysts
Average Return
+22.5%
Win Rate
45%65 out of 145
Risk vs Reward
Poor
Good
Gregory Renza's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Adc Therapeutics SaADCT | +693.33% | $0.60 | $4.76 | 2023-11-07 - 2024-04-18 | Buy |
Prometheus Biosciences IncRXDX | +603.13% | $27.52 | $193.50 | 2022-05-12 - 2023-04-18 | Buy |
Alpine Immune Sciences IncALPN | +428.30% | $12.19 | $64.40 | 2023-10-04 - 2024-04-11 | Buy |
Adc Therapeutics SaADCT | +398.43% | $0.96 | $4.76 | 2023-09-11 - 2024-04-18 | Buy |
Alpine Immune Sciences IncALPN | +300.75% | $16.07 | $64.40 | 2023-11-02 - 2024-04-11 | Buy |
Gregory Renza Analyst Color
Get additional color on Gregory Renza's coverage of popular stocks
Gregory Renza's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Nurix Therapeutics IncNRIX | 7 | Buy | $23.00 | +59.28% | Maintains | 9 days ago |
Alpine Immune Sciences IncALPN | 4 | Hold | $65.00 | +0.88% | Downgrades | 9 days ago |
Amgen IncAMGN | 10 | Buy | $329.00 | +25.21% | Reiterates | 17 days ago |
Jasper Therapeutics IncJSPR | 1 | Buy | $70.00 | +201.59% | Initiates Coverage On | 23 days ago |
Fusion Pharmaceuticals IncFUSN | 4 | Hold | $21.00 | -1.18% | Reiterates | a month ago |
Atyr Pharma IncLIFE | 5 | Buy | $16.00 | +887.65% | Maintains | a month ago |
Verastem IncVSTM | 5 | Buy | $32.00 | +212.81% | Reiterates | a month ago |
Adc Therapeutics SaADCT | 10 | Buy | $8.00 | +68.07% | Reiterates | a month ago |
Spruce Biosciences IncSPRB | 9 | Hold | $2.00 | +185.31% | Downgrades | a month ago |
Fulcrum Therapeutics IncFULC | 1 | Buy | $14.00 | +98.30% | Initiates Coverage On | a month ago |
Cormedix IncCRMD | 3 | Buy | $9.00 | +66.05% | Maintains | a month ago |
Acadia Pharmaceuticals IncACAD | 11 | Buy | $30.00 | +75.75% | Maintains | a month ago |
Inovio Pharmaceuticals IncINO | 6 | Hold | $11.00 | +7.84% | Reiterates | a month ago |
Pacira Biosciences IncPCRX | 6 | Buy | $45.00 | +72.41% | Maintains | 2 months ago |
Jazz Pharmaceuticals PLCJAZZ | 7 | Buy | $195.00 | +78.46% | Reiterates | 2 months ago |
Xencor IncXNCR | 5 | Buy | $32.00 | +68.87% | Reiterates | 2 months ago |
Ideaya Biosciences IncIDYA | 8 | Buy | $53.00 | +40.88% | Maintains | 2 months ago |
Agios Pharmaceuticals IncAGIO | 1 | Buy | $42.00 | +42.71% | Maintains | 2 months ago |
Exelixis IncEXEL | 3 | Buy | $28.00 | +24.50% | Maintains | 2 months ago |
Viridian Therapeutics IncVRDN | 6 | Buy | $35.00 | +130.87% | Reiterates | 4 months ago |
Viracta Therapeutics IncVIRX | 6 | Buy | $6.00 | +560.07% | Maintains | 5 months ago |
Aptose Biosciences IncAPTO | 7 | Buy | $18.00 | +1,317.32% | Maintains | 5 months ago |
Verrica Pharmaceuticals IncVRCA | 4 | Buy | $14.00 | +102.90% | Maintains | 9 months ago |
Avalo Therapeutics IncAVTX | 4 | Hold | $180.00 | +1,398.75% | Downgrades | 10 months ago |
Bellus Health IncBLU | 8 | Hold | $14.75 | +0.07% | Reiterates | a year ago |
Prometheus Biosciences IncRXDX | 6 | Hold | $200.00 | +0.04% | Maintains | a year ago |
Nuvation Bio IncNUVB | 3 | Buy | $5.00 | +93.80% | Maintains | a year ago |
Morphic Holding IncMORF | 5 | Buy | $80.00 | +190.80% | Maintains | a year ago |
Seagen IncSGEN | 5 | Buy | $229.00 | N/A | Maintains | a year ago |
Global Blood Therapeutics IncGBT | 3 | Hold | $68.50 | N/A | Downgrades | 2 years ago |
Aprea Therapeutics IncAPRE | 5 | Hold | $80.00 | N/A | Maintains | 2 years ago |
Provention Bio IncPRVB | 2 | Hold | $10.00 | N/A | Downgrades | 3 years ago |
Iterum Therapeutics PLCITRM | 3 | Hold | $30.00 | N/A | Downgrades | 4 years ago |
Portola Pharmaceuticals IncPTLA | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 4 years ago |
Arqule IncARQL | 1 | Hold | $20.00 | N/A | Downgrades | 4 years ago |
Gamida Cell LtdGMDAQ | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.